Invention Grant
- Patent Title: Use of pentagastrin to inhibit gastric acid secretion or as a diuretic
- Patent Title (中): 使用五肽胃泌素抑制胃酸分泌或利尿
-
Application No.: US11608667Application Date: 2006-12-08
-
Publication No.: US07807623B2Publication Date: 2010-10-05
- Inventor: Joseph R. Pisegna , Stephen Wank
- Applicant: Joseph R. Pisegna , Stephen Wank
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Weaver Austin Villeneuve & Sampson LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K49/00
Abstract:
This invention pertains to the discovery administration of a CCK receptor agonist can increase urinary sodium excretion and/or free water excretion in a mammal. CCK receptor agonist can thereby be used in the treatment of conditions such high blood pressure, fluid retention associated with heart failure, fluid retention associated with acute or chronic kidney failure, fluid retention associated with cirrhosis, fluid retention associated with liver failure, calcium kidney stones, nephrogenic diabetes insipidus, and renal tubular acidosis.
Public/Granted literature
- US20070207959A1 USE OF PENTAGASTRIN TO INHIBIT GASTRIC ACID SECRETION OR AS A DIURETIC Public/Granted day:2007-09-06
Information query
IPC分类:
